Tris(pyrazolyl)methane 99mtc tricarbonyl complexes for myocardial imaging

Area of Science:

• Radiochemistry
• Nuclear Medicine
• Coordination Chemistry

Background:

• The technetium-99m (99mTc) core is crucial for radiopharmaceuticals.
• Stabilizing the fac-[99mTc(CO)3]+ moiety is key for developing effective imaging agents.
• Tris(pyrazolyl)methane ligands offer versatile coordination properties.

Purpose of the Study:

• To synthesize and characterize novel ether-containing tris(pyrazolyl)methane chelators.
• To evaluate the stability and biodistribution of the resulting fac-[99mTc(CO)3]+ complexes.
• To assess their potential as cardiac imaging agents.

Main Methods:

• Synthesis of novel ether-containing tris(pyrazolyl)methane ligands.
• Radiolabeling with technetium-99m to form fac-[99mTc(CO)3]+ complexes.
• In vitro stability studies and in vivo biodistribution in animal models.

Main Results:

• The novel chelators successfully stabilized the fac-[99mTc(CO)3]+ moiety.
• The resulting complexes exhibited significant and rapid uptake in the heart.
• Extremely fast clearance from the liver was observed, minimizing background interference.

Conclusions:

• Ether-containing tris(pyrazolyl)methane chelators are effective in stabilizing the fac-[99mTc(CO)3]+ core.
• These novel complexes demonstrate excellent properties for cardiac imaging, including fast heart uptake and rapid liver clearance.
• This work presents promising new radiotracers for nuclear cardiology applications.